(Reuters) -Novo Nordisk and Eli Lilly ( LLY ) do not have a weight-loss drug partnership with telehealth website Mangoceuticals Inc ( MGRX ), spokespeople for both companies said, rejecting a press release issued by the company on Thursday that described arrangements with the two leading drugmakers.

Spokespeople for both companies said in emails to Reuters that they had no special arrangements with the company.

Mangoceuticals ( MGRX ) did not respond to request for comment.